Company lists · Data refreshed September 2026
Top 15 Regenerative medicine venture capital firms based in Switzerland
RevenueBase identified 30 regenerative medicine venture capital firms headquartered in Switzerland as of September 2026 and tracks 179 professional contacts across them, including 75 with verified work emails. Zurich is the largest hub.
This list covers regenerative medicine venture capital firms headquartered in Switzerland, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 29, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 15 largest regenerative medicine venture capital firms based in Switzerland
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 25 contacts → | ||||
Strong evidence “Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 2 | 24 contacts → | ||||
Indirect evidence “HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 3 | 12 contacts → | ||||
Strong evidence “Convergence Partners is a European venture capital firm that invests in founders building high-impact companies in healthcare sectors with large unmet needs.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 4 | 11 contacts → | ||||
Strong evidence “Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of…” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 5 | 10 contacts → | ||||
Strong evidence “Endeavour Vision is a leading venture capital and growth equity advisory firm focusing on commercial-stage medtech and digital health companies.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 6 | 9 contacts → | ||||
Partial evidence “DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 7 | 7 contacts → | ||||
Strong evidence “Unicyte AG is a transformative regenerative medicine company advancing stem cell technologies into a novel class of human therapeutics.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 8 | 6 contacts → | ||||
Partial evidence “MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 9 | 4 contacts → | ||||
Partial evidence “SwissHealth Ventures investiert in Startups, die sich mit ihren Ideen für ein qualitativ hochwertiges und kosteneffizientes Gesundheitssystem einsetzen.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 10 | 4 contacts → | ||||
Partial evidence “IMAGINE.A future for our children and grandchildren, whose medical care is governed and guided by health and not disease: safe stem cell treatments and regenerative therapies that…” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 11 | 4 contacts → | ||||
Indirect evidence “Biotech fund” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 12 | 4 contacts → | ||||
Partial evidence “Corpus Health aims to develop ventures that offer innovative and disruptive products and services in the medical field” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 13 | 4 contacts → | ||||
Indirect evidence “Helsana HealthInvest invested in start-ups dedicated to health as a way of contributing to a higher quality of healthcare and increasing efficiency in the healthcare system.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 14 | 2 contacts → | ||||
Strong evidence “endogena’s mission is to discover and develop first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
| 15 | 1 contacts → | ||||
Strong evidence “At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality.” Source: RevenueBase Database · checked Sep 29, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: regenerative medicine venture capital firms. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names regenerative medicine venture capital firms.
- Partial evidence
- Its own public description names part of regenerative medicine venture capital firms, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name regenerative medicine venture capital firms. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 15 of 30 regenerative medicine venture capital firms based in Switzerland
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 75 reachable decision-makers.
Free signup · no credit card
Regenerative medicine venture capital firms based in Switzerland at a glance
As of Sep 29, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for Switzerland, so it is reported there. Company counts and contact totals on this page are exact for Switzerland, over 30 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among regenerative medicine venture capital firms, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Switzerland whose own description of what they do matches “regenerative medicine venture capital firms”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names regenerative medicine venture capital firms), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among regenerative medicine venture capital firms, and records with no verified work email. Companies headquartered outside Switzerland are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 75 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 29, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names regenerative medicine venture capital firms, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many regenerative medicine venture capital firms are there based in Switzerland?
RevenueBase identified 30 regenerative medicine venture capital firms headquartered in Switzerland as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Nextech Invest, headquartered in Zurich, tops this list with the largest team on record.
Which city has the most regenerative medicine venture capital firms?
Zurich leads with 7 headquartered companies, followed by Zug (3) and Geneva (2).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 75 verified decision-maker contacts tracked across these 30 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 29, 2026.
Ready to reach these companies? Verified emails and direct dials for all 30 regenerative medicine venture capital firms based in Switzerland. Start with a free account, no credit card.
Download this list →Related lists
Regenerative medicine venture capital firms by geography
- Regenerative medicine venture capital firms based in London, United Kingdom
- Regenerative medicine venture capital firms based in Boston, United States
- Regenerative medicine venture capital firms based in New York, United States
- Regenerative medicine venture capital firms based in San Francisco, United States
- Regenerative medicine venture capital firms based in Australia
- Regenerative medicine venture capital firms based in Canada
- Regenerative medicine venture capital firms based in Germany
- Regenerative medicine venture capital firms based in the United Kingdom
- Regenerative medicine venture capital firms based in the United States
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Regenerative medicine venture capital firms based in London, United Kingdom
- Regenerative medicine venture capital firms based in Boston, United States
- Regenerative medicine venture capital firms based in New York, United States
- Regenerative medicine venture capital firms based in San Francisco, United States
- Regenerative medicine venture capital firms based in Australia
- Regenerative medicine venture capital firms based in Canada